Martin Hunt
Chairman presso SKINBIOTHERAPEUTICS PLC
Patrimonio netto: 90 261 $ in data 31/03/2024
Profilo
Martin Braddock Hunt is currently the Chairman of Videregen Ltd., the Non-Executive Chairman of SkinBioTherapeutics Plc, the Programme Director of i4i LP, a Director of Invictus Management Ltd., and a Programme Director of the National Institute for Health & Care Research.
Previously, he was the Chief Executive Officer of Tissue Science Laboratories Ltd., the Deputy Chairman of MDY Healthcare Ltd., the Vice Chairman-Supervisory Board of Trophos SA, the Marketing Director-Europe, Middle East & Africa of Wyeth Holdings LLC, a Director of ArcticZymes Technologies ASA, a Director of DYSIS Medical Ltd., a Director of Tissue Science Laboratories (UK) Ltd., a Director of Regentix Ltd., a Non-Executive Director of Orthox Ltd., and the Vice President-Europe Sales of Bristol Myers Squibb Co.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SKINBIOTHERAPEUTICS PLC
0.29% | 30/06/2023 | 560 417 ( 0.29% ) | 90 261 $ | 31/03/2024 |
Posizioni attive di Martin Hunt
Società | Posizione | Inizio |
---|---|---|
SKINBIOTHERAPEUTICS PLC | Chairman | 03/10/2016 |
Invictus Management Ltd.
Invictus Management Ltd. Miscellaneous Commercial ServicesCommercial Services Invictus Management Ltd. is an Irish private company located in Dublin that provides business and management consulting services. | Director/Board Member | 13/12/2010 |
National Institute For Health & Care Research
National Institute For Health & Care Research Miscellaneous Commercial ServicesCommercial Services National Institute for Health Research improves the health and wealth of the nation through research. It provides support for applied health research focused on the needs of patients and the public. The company was founded in April 2006 and is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
i4i LP | Corporate Officer/Principal | - |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Chairman | - |
Precedenti posizioni note di Martin Hunt
Società | Posizione | Fine |
---|---|---|
Tissue Science Laboratories (UK) Ltd. | Director/Board Member | - |
ARCTICZYMES TECHNOLOGIES ASA | Director/Board Member | - |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Director/Board Member | - |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Chairman | - |
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
Aziende private | 13 |
---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
i4i LP | |
MDY Healthcare Ltd.
MDY Healthcare Ltd. Financial ConglomeratesFinance MDY Healthcare Ltd. engaged in the provision of healthcare products. It offered a diabetes management, and medical safety products. The company was founded in 1984 and was headquartered in Guildford, the United Kingdom. | Finance |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom. | Health Technology |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Health Technology |
Tissue Science Laboratories (UK) Ltd. | |
Regentix Ltd. | |
Invictus Management Ltd.
Invictus Management Ltd. Miscellaneous Commercial ServicesCommercial Services Invictus Management Ltd. is an Irish private company located in Dublin that provides business and management consulting services. | Commercial Services |
Orthox Ltd.
Orthox Ltd. BiotechnologyHealth Technology Orthox Ltd. develops tissue regenerative implants. The firm?s products include FibroFix Meniscus and FibroFix Cartilage. The company was founded by Nicholas James Vavasour Skaer and Oliver Kessler in 2008 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
National Institute For Health & Care Research
National Institute For Health & Care Research Miscellaneous Commercial ServicesCommercial Services National Institute for Health Research improves the health and wealth of the nation through research. It provides support for applied health research focused on the needs of patients and the public. The company was founded in April 2006 and is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Health Technology |
SkinBioTherapeutics Plc |
- Borsa valori
- Insiders
- Martin Hunt